Old Web
English
Sign In
Acemap
>
authorDetail
>
Jenna A Bosco
Jenna A Bosco
multicenter study
Monoclonal antibody
Medicine
Antigen
Epitope
2
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis:
2020
Multiple Sclerosis Journal
Edward Fox
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Maria Petracca
Sirio Cocozza
Richard A. Shubin
Sibyl Wray
Michael S. Weiss
Jenna A Bosco
Sean A Power
Koby Mok
Matilde Inglese
Show All
Source
Cite
Save
Citations (23)
Final Results of a Phase 2 Multicenter Study of Ublituximab, a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Patients with RMS
2019
Edward J. Fox
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Maria Petracca
Matilde Inglese
S. Cocozza
Sibyl Wray
Richard Shubin
Jenna A Bosco
Sean A Power
Michael D. Weiss
Koby Mok
James L Eubanks
Show All
Source
Cite
Save
Citations (0)
1